Bonvests Holdings Limited (SGX:B28)

Intra-Cellular Therapies Revenue

In the year 2024, Bonvests Holdings had annual revenue of 225.04M SGD with 3.44% growth. Bonvests Holdings had revenue of 115.23M in the half year ending December 31, 2024, a decrease of -0.84%.

• Revenue: 225.04M
• Revenue Growth: +3.44%
• P/S Ratio: 1.77
• Revenue / Employee: 2.25M
• Employees: 100
• Market Cap: 397.50M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	225.04M	7.49M	3.44%
Dec 31, 2023	217.55M	7.88M	3.76%
Dec 31, 2022	209.67M	74.64M	55.28%
Dec 31, 2021	135.03M	13.58M	11.18%
Dec 31, 2020	121.45M	-107.55M	-46.96%